181 related articles for article (PubMed ID: 33128779)
1. Histone lysine demethylases and their functions in cancer.
Sterling J; Menezes SV; Abbassi RH; Munoz L
Int J Cancer; 2021 May; 148(10):2375-2388. PubMed ID: 33128779
[TBL] [Abstract][Full Text] [Related]
2. The role and prospect of lysine-specific demethylases in cancer chemoresistance.
Song YQ; Yang GJ; Ma DL; Wang W; Leung CH
Med Res Rev; 2023 Sep; 43(5):1438-1469. PubMed ID: 37012609
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Enzyme Assays for JmjC-Domain-Containing Lysine Histone Demethylases (JmjC-KDMs).
Tarhonskaya H; Tumber A; Kawamura A; Schofield CJ
Curr Protoc Pharmacol; 2018 Mar; 80(1):3.15.1-3.15.12. PubMed ID: 30040204
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of histone lysine demethylases in prostate cancer.
Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD
Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098
[TBL] [Abstract][Full Text] [Related]
5. Lysine Demethylation in Pathogenesis.
Cao J; Yan Q
Adv Exp Med Biol; 2023; 1433():1-14. PubMed ID: 37751133
[TBL] [Abstract][Full Text] [Related]
6. Targeting histone demethylases as a potential cancer therapy (Review).
Diao W; Zheng J; Li Y; Wang J; Xu S
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35801593
[TBL] [Abstract][Full Text] [Related]
7. Histone Methylases and Demethylases Regulating Antagonistic Methyl Marks: Changes Occurring in Cancer.
Taylor-Papadimitriou J; Burchell JM
Cells; 2022 Mar; 11(7):. PubMed ID: 35406676
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15.
Duan L; Perez RE; Calhoun S; Maki CG
Cancer Biol Ther; 2022 Dec; 23(1):65-75. PubMed ID: 35100078
[TBL] [Abstract][Full Text] [Related]
9. Assessing histone demethylase inhibitors in cells: lessons learned.
Hatch SB; Yapp C; Montenegro RC; Savitsky P; Gamble V; Tumber A; Ruda GF; Bavetsias V; Fedorov O; Atrash B; Raynaud F; Lanigan R; Carmichael L; Tomlin K; Burke R; Westaway SM; Brown JA; Prinjha RK; Martinez ED; Oppermann U; Schofield CJ; Bountra C; Kawamura A; Blagg J; Brennan PE; Rossanese O; Müller S
Epigenetics Chromatin; 2017; 10():9. PubMed ID: 28265301
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic gene regulation by histone demethylases: emerging role in oncogenesis and inflammation.
Kang MK; Mehrazarin S; Park NH; Wang CY
Oral Dis; 2017 Sep; 23(6):709-720. PubMed ID: 27514027
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.
Dorna D; Paluszczak J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326475
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic roles of KDM3B and KDM3C in tumorigenesis and their therapeutic implications.
Yoo J; Kim GW; Jeon YH; Lee SW; Kwon SH
Cell Death Dis; 2024 Jun; 15(6):451. PubMed ID: 38926399
[TBL] [Abstract][Full Text] [Related]
13. Deferiprone: Pan-selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study.
Khodaverdian V; Tapadar S; MacDonald IA; Xu Y; Ho PY; Bridges A; Rajpurohit P; Sanghani BA; Fan Y; Thangaraju M; Hathaway NA; Oyelere AK
Sci Rep; 2019 Mar; 9(1):4802. PubMed ID: 30886160
[TBL] [Abstract][Full Text] [Related]
14. Jumonji histone demethylases as emerging therapeutic targets.
Park SY; Park JW; Chun YS
Pharmacol Res; 2016 Mar; 105():146-51. PubMed ID: 26816087
[TBL] [Abstract][Full Text] [Related]
15. Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.
Tian X; Zhang S; Liu HM; Zhang YB; Blair CA; Mercola D; Sassone-Corsi P; Zi X
Curr Cancer Drug Targets; 2013 Jun; 13(5):558-79. PubMed ID: 23713993
[TBL] [Abstract][Full Text] [Related]
16. Taking Me away: the function of phosphorylation on histone lysine demethylases.
Karakatsanis NM; Hamey JJ; Wilkins MR
Trends Biochem Sci; 2024 Mar; 49(3):257-276. PubMed ID: 38233282
[TBL] [Abstract][Full Text] [Related]
17. Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.
Wang Z; Patel DJ
Q Rev Biophys; 2013 Nov; 46(4):349-73. PubMed ID: 23991894
[TBL] [Abstract][Full Text] [Related]
18. Targeting histone lysine demethylases - progress, challenges, and the future.
Thinnes CC; England KS; Kawamura A; Chowdhury R; Schofield CJ; Hopkinson RJ
Biochim Biophys Acta; 2014 Dec; 1839(12):1416-32. PubMed ID: 24859458
[TBL] [Abstract][Full Text] [Related]
19. A scintillation proximity assay for histone demethylases.
Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ
Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
He X; Zhang H; Zhang Y; Ye Y; Wang S; Bai R; Xie T; Ye XY
Eur J Med Chem; 2022 Mar; 231():114143. PubMed ID: 35101649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
